Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07874022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Decision Regret Following Yonsei-Point Botulinum Toxin for Gummy Smile

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Cairo University
1,562 trials monitored
See 18 trials at risk
This study evaluates patient-reported decision regret in adult patients who previously received standardized Botulinum Toxin Type A (BoNT-A) injection at the Yonsei Point for excessive gingival display (gummy smile). While BoNT-A provides predictable millimetric reduction in gingival exposure, subjective patient satisfaction and cognitive-emotional remorse remain under-investigated in periodontal plastic literature. Eligible patients will be identified from hospital treatment records at Cairo University Faculty of Dentistry. Patient-reported decision regret will be measured at 3 months post-treatment using the Ottawa Decision Regret Scale (ODRS). Archived clinical and photogrammetric smile records will also be audited to evaluate gingival display reduction in millimeters.
Trial Details
NCT Number NCT07874022
Lead Sponsor Cairo University
Conditions
(from sponsor)		 Excessive Gingival Display
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov